| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |